ANRO SG&A Expense Growth
Alto Neuroscience, Inc. Common Stock · SG&A Expense Growth
ANRO SG&A Expense Growth
Latest reported-4.02%period ending
ANRO FY SG&A Growth (YoY) (0.00% → -4.02%)
Latest values, visible window
High-resolution chart · PNG
ANRO sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -4.0205% | |
| 187.4967% | |
| 45.6412% | |
| 37.6166% | |
| 0% |